MDT Q2'26 Earnings: revenue estimate is 9.48B USD
Medtronic (MDT) is scheduled to release Q2'26 earnings on November 24, with estimated revenue of $9.48B and EPS of $1.33. Results will be announced at 6:45 AM ET.
How this was made

The 30-second read
Why it matters
The provided consensus revenue and EPS create a reference point for traders to gauge whether the eventual report is likely to beat or miss, but no new company-specific information is disclosed yet.
Market read
Useful for timing and expectation-setting ahead of the earnings release, but it is not a first report of new fundamentals.
What to watch
Actual price reaction will depend on guidance, margins, and segment trends, none of which are disclosed here.
Background
The article is a pre-earnings setup for Medtronic’s Q2'26 results, scheduled for Nov 24 before the market opens.
Ticker impact
Medtronic is scheduled to report Q2'26 results Nov 24, with consensus revenue of $9.48B and EPS of $1.33.
Likely volatility into the Nov 24 pre-market earnings window as the market compares the actual print to the provided consensus figures.
The article provides a scheduled earnings date and consensus estimates, but it does not include any surprise, guidance change, or newly disclosed company-specific development.
Market effects
A large medtech earnings event can influence near-term sentiment and positioning across medical devices, but the article itself is only a scheduling/consensus setup.
Primarily impacts US-listed medtech trading around the pre-market earnings window.
Limited global spillover from a single-company earnings date and consensus estimates.
Counterpoint
Because the piece only states consensus expectations and timing, it may not justify new positioning beyond normal earnings-volatility management.
Key entities
- companyMedtronic plc.
Subject of the earnings preview, scheduled to report Q2'26 results on Nov 24 before the market opens.

